Local Institution - 0033

Westmead, New South Wales 2145

1 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Melanoma

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — Recruiting now
• A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma — Running, not enrolling